Products
Product information
MEDI-EXAMETAZIME
Active substance
Exametazime 0.5 mg
Indications
Neurology:
- Evaluation of patients with cerebrovascular disease (specifically acute stroke, chronic ischemia, and transient ischemic attack)
- Presurgical lateralization and localization of epileptogenic foci.
- Evaluation of patients with suspected dementia (specifically Alzheimer’s disease and frontotemporal dementia)
- Evaluation of patients with migraine
- Adjuvant technique in the diagnosis of brain death
Infectious or inflammatory diseases
- Localisation of abnormal foci guiding the aetiologic diagnosis in case of fever of unknown origin
- Diagnosis of infection in case of suspected osteomyelitis (with or without implants) and suspected hip or knee prosthesis infection.
- Detection of the extension of inflammation in case of inflammatory bowel disease.
Excipients
- Stannous(II) chloride dihydrate
- Tetrasodium pyrophosphate decahydrate
Dose for adults
Brain perfusion SPECT: 350-500 MBq
Labelled leucocyte scintigraphy: 200 MBq
Labelling volume
5 ml
Labelling activity
0.37-2.2 GBq
Storage of cold kit
12 months from date of manufacturing,
Store at 2-8°C
Storage of labelled compound
1 hr,
Do not store above 25°C
Protect from light
Package size
6 vials
Registration numbers
Denmark: DK R 49482
Germany: 86253.00.00
Austria: 4-00051
United Kingdom: PL40129/0001M
Turkey: 135/53
Spain: 77468
Italy: AIC n 042496024
Hong-Kong: HK-64514
Marketing Authorization Holder
Radiopharmacy Laboratory Ltd.
2040 Budaörs, Gyár u. 2., Hungary
Sales Information
For more information: